Robert Clarke, Ph.D., D.Sc., is the Dean for Research at Georgetown University Medical Center and co-Director of the Breast Cancer Program at the Georgetown-Lombardi Comprehensive Cancer Center. Dr. Clarke's research interests include the cellular and molecular mechanisms driving endocrine resistance in breast cancer as well as drug resistance, drug/hormone interactions, and the application of molecular profiling to predict breast cancer phenotypes and identify functionally relevant gene signaling networks. Dr. Clarke leads several multinational molecular medicine studies in breast cancer, in collaboration with colleagues at Lombardi Comprehensive Cancer Center, Virginia Tech and the University of Edinburgh. Dr. Clarke received a PhD and DSc in Biochemistry from The Queen’s University of Belfast, UK.